Entity

Time filter

Source Type

Cambridge, MA, United States

Patent
Blueprint Medicines | Date: 2014-06-27

Described herein are inhibitors of FGFR, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.


Patent
Blueprint Medicines | Date: 2014-10-17

Compounds and compositions useful for treating disorders related to KIT and PDFGR are described herein.


Patent
Blueprint Medicines | Date: 2015-10-20

Compounds and compositions useful for treating disorders related to mutant KIT are described herein.


Patent
Blueprint Medicines | Date: 2015-08-04

Compounds and compositions useful for treating disorders related to Kit are described herein.


Patent
Blueprint Medicines | Date: 2013-07-11

Described herein are inhibitors of FGFR, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.

Discover hidden collaborations